<SEC-DOCUMENT>0001072613-24-000515-index.html : 20240517 <SEC-HEADER>0001072613-24-000515.hdr.sgml : 20240517 <ACCEPTANCE-DATETIME>20240517182514 ACCESSION NUMBER: 0001072613-24-000515 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 GROUP MEMBERS: ALI BEHBAHANI GROUP MEMBERS: ANTHONY A. FLORENCE, JR. GROUP MEMBERS: CARMEN CHANG GROUP MEMBERS: FOREST BASKETT GROUP MEMBERS: MOHAMAD H. MAKHZOUMI GROUP MEMBERS: NEA 16 GP, LLC GROUP MEMBERS: NEA PARTNERS 16, L.P. GROUP MEMBERS: PAUL WALKER GROUP MEMBERS: SCOTT D. SANDELL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-58217 FILM NUMBER: 24961869 BUSINESS ADDRESS: STREET 1: 4551 KENNEDY COMMERCE DR. CITY: HOUSTON STATE: TX ZIP: 77032 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 4551 KENNEDY COMMERCE DR. CITY: HOUSTON STATE: TX ZIP: 77032 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: New Enterprise Associates 16, L.P. CENTRAL INDEX KEY: 0001694560 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 1954 GREENSPRING DRIVE STREET 2: SUITE 600 CITY: TIMONIUM STATE: MD ZIP: 21093 BUSINESS PHONE: 410-842-4000 MAIL ADDRESS: STREET 1: 1954 GREENSPRING DRIVE STREET 2: SUITE 600 CITY: TIMONIUM STATE: MD ZIP: 21093 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D/A <SEQUENCE>1 <FILENAME>nea16-marker_18847.htm <DESCRIPTION>NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A(#2) <TEXT> Document 1 - file: nea16-marker_18847.htm
</DOCUMENT> </SEC-DOCUMENT>